Nicole Sweeny, Chief Commercial Officer at KalVista Pharmaceuticals, Inc. (KALV), sold 7,950 shares at $15.57 ($124K) on 2026-02-23, disclosed to the SEC on 2026-02-24.
Open-market sale of $124k KALV by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.57 | 3,975 | $62K | 50.0% |
| 2 | $15.57 | 3,975 | $62K | 50.0% |
| Total | $15.57 avg | 7,950 | $124K | 100% |
| Filing → |
| KALV | SELL | 2026-04-20 | $38K | — | Filing → |
| KALV | SELL | 2025-12-04 | $103K | — | Filing → |
| KALV | SELL | 2025-08-26 | $20K | — | Filing → |